| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Edwin Kania is Director at RNAC, with reported holdings spanning 2 companies. Edwin Kania's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $21.3M at current prices.
Edwin Kania's largest disclosed position is in TMDX as Director, worth about $17.8M. Net of sales, the TMDX filings show accumulation of 133,333 shares.
Edwin Kania has 14 Form 4 filings on record from June 2016 to May 2026, across 2 companies: Director at TransMedics Group (TMDX), 2019–2026; Director at Cartesian Therapeutics (RNAC), 2016–2017.
The 36 reported transactions were 15 other transactions, 8 conversions, 4 stock awards and 4 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $2.8M and 1 sale worth about $3.7M.
The largest open-market purchase was 100,000 shares of TMDX at an average $22.56 on November 29, 2021, about $2.3M. Twelve months later TMDX was up 167%.
The only open-market sale was 266,795 shares of RNAC at an average $14.00 on May 16, 2017, about $3.7M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | TMDX Transmedics Group, Inc. | Director | Buy | 100,000 | $22.56 | $2,256,215.34 | +49.3% | -15.0% | +166.8% | |
| May 6, 2019 | TMDX Transmedics Group, Inc. | Director | Buy | 33,333 | $16.00 | $533,328.00 | New | - | - | |
| May 16, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Sell | 266,795 | $14.00 | $3,735,130.00 | -32.3% | - | - |